drugset / Trial / NCT00914511

A Pharmacokinetic Study of Avanfil in Healthy Young Male Subjects

NCT00914511

Phase 1 Completed 32 enrolled VIVUS LLC
Non-randomizedSingle-groupOpen-labelBasic science

Summary

The purposes of this study are to: * Determine the effect of the study drug on sperm and semen of healthy young male subjects. * Determine the effect of age on the amount of study drug in the blood of healthy subjects * Learn about the safety of the study drug. * Learn how subjects tolerate the study drug.

Timeline

Start
2009-05
Primary completion
2009-06
Completion
2009-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Avanafil Small molecule 200 mg Oral

Indications

No indication recorded.